OraSure Technologies Inc (OSUR)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

150 WEBSTER ST BETHLEHEM, PA 18015

OraSure Technologies is engaged in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Co. also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. Co.'s diagnostic products include tests that are performed on a rapid basis at the point of care and tests that are processed in a laboratory. Co.'s products are sold to clinical laboratories, hospitals, clinics, and physicians' offices.

Data based on most recent fiscal year report
Market Cap501.865 Million Shares Outstanding61.73 Million Avg Volume810.006 Thousand
1-Yr BETA vs S&P TR1.614 Current Ratio7.84 Quick Ratio7.02
View SEC Filings from OSUR instead.

View recent insider trading info

Funds Holding OSUR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OSUR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SARIN ARADHANA EVP, CFO

  • Officer
24,760 2019-12-02 2

GOLDSTEIN JACK

  • Director
183,282 2019-11-29 0

MENDEZ MANUEL O. SVP & CHIEF COMMERCIAL OFFICER

  • Officer
24,626 2019-11-19 0

MICHELS DOUGLAS A

  • Director
0 2019-08-22 0

DATIN JAMES A DIRECTOR

13,432 2019-08-12 2

ASPINALL MARA G.

  • Director
40,848 2019-07-29 1

SPAIR RONALD H

19,072 2019-06-01 0

CELANO MICHAEL DIRECTOR

62,642 2019-05-21 1

LANCASTER RONNY B DIRECTOR

21,029 2019-05-21 2

PATRICK CHARLES W DIRECTOR

62,436 2019-05-21 2

HOBBS EAMONN P DIRECTOR

30,502 2019-05-21 2

TANG STEPHEN S PHD PRESIDENT AND CEO

119,960 2019-05-14 3

JERRETT JACK E SVP & GENERAL COUNSEL

91,885 2019-05-13 2

CUCA ROBERTO CFO

47,575 2019-05-10 3

REED MICHAEL SVP R&D AND CSO

49,217 2019-04-18 2

ZEZZO II ANTHONY EVP & BU LEAD - INFECTIOUS

183,610 2019-02-01 1

MILLER MICHELE MARIE VP, FINANCE AND CONTROLLER

8,071 2019-02-01 1

WEBER KATHLEEN GALLAGHER EVP & BU LEAD - MOLECULAR

63,379 2019-02-01 1

KUNA MARK L SEE REMARKS

  • Officer
No longer subject to file 2018-10-22 0

SMITH BRIAN EVP & BU LEAD - MOLECULAR

  • Officer
18,075 2018-02-15 0

PRINGLE ROGER L

  • Director
No longer subject to file 2017-05-15 0

WATSON DOUGLAS G

  • Director
No longer subject to file 2016-11-13 0

OSTROV GERALD M

  • Director
24,896 2015-02-23 0

WHITTERS ERIC SVP, RESEARCH AND DEVELOPMENT

  • Officer
9,857 2015-02-03 0

LEE STEPHEN R EXEC. VP & CSO

  • Officer
55,815 2014-02-01 0

FORMICA P MICHAEL EXEC. VP & GM CRYO. SYS. DIV.

  • Officer
147,874 2009-08-19 0

ZACK JOSEPH E EXEC. VP - MKTG. & SALES

  • Officer
58,050 2008-01-26 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments